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Abstract 
Background: Microbial production of lycopene, a commercially and medically important compound, has received 
increasing concern in recent years. Saccharomyces cerevisiae is regarded as a safer host for lycopene production than 
Escherichia coli. However, to date, the lycopene yield (mg/g DCW) in S. cerevisiae was lower than that in E. coli and did 
not facilitate downstream extraction process, which might be attributed to the incompatibility between host cell and 
heterologous pathway. Therefore, to achieve lycopene overproduction in S. cerevisiae, both host cell and heterologous 
pathway should be delicately engineered.
Results: In this study, lycopene biosynthesis pathway was constructed by integration of CrtE, CrtB and CrtI in S. 
cerevisiae CEN.PK2. When YPL062W, a distant genetic locus, was deleted, little acetate was accumulated and approxi-
mately 100 % increase in cytosolic acetyl-CoA pool was achieved relative to that in parental strain. Through screening 
CrtE, CrtB and CrtI from diverse species, an optimal carotenogenic enzyme combination was obtained, and CrtI from 
Blakeslea trispora (BtCrtI) was found to have excellent performance on lycopene production as well as lycopene pro-
portion in carotenoid. Then, the expression level of BtCrtI was fine-tuned and the effect of cell mating types was also 
evaluated. Finally, potential distant genetic targets (YJL064W, ROX1, and DOS2) were deleted and a stress-responsive 
transcription factor INO2 was also up-regulated. Through the above modifications between host cell and caroteno-
genic pathway, lycopene yield was increased by approximately 22-fold (from 2.43 to 54.63 mg/g DCW). Eventually, in 
fed-batch fermentation, lycopene production reached 55.56 mg/g DCW, which is the highest reported yield in yeasts.
Conclusions: Saccharomyces cerevisiae was engineered to produce lycopene in this study. Through combining host 
engineering (distant genetic loci and cell mating types) with pathway engineering (enzyme screening and gene fine-
tuning), lycopene yield was stepwise improved by 22-fold as compared to the starting strain. The highest lycopene 
yield (55.56 mg/g DCW) in yeasts was achieved in 5-L bioreactors. This study provides a good reference of combinato-
rial engineering of host cell and heterologous pathway for microbial overproduction of pharmaceutical and chemical 
products.
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Background
Artificial biosynthetic pathway and host cell are two 
fundamental elements for microbe-based heterologous 
biosynthesis of natural products. On one hand, poten-
tial metabolic and regulatory issues from host cell play 
an important role in pathway productivity [1–4]. One-
hundred distant genetic loci that are not directly involved 
in target pathway were identified to influence carotenoid 
production significantly in Saccharomyces cerevisiae [5]. 
On the other hand, balanced metabolic flux between 
modules in target pathway is another important issue to 
improve pathway performance. Through multivariate-
modular optimization of taxadiene metabolic pathway, 
a 15,000-fold increase in taxadiene titer was observed 
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in Escherichia coli [6]. A “push–pull-block” pathway 
manipulation strategy significantly enhanced terpenoids 
production in yeasts [7, 8]. Thus, optimal pathway out-
put can be achieved by means of delicate engineering of 
both target pathway and host cell [9]. It was reported that 
bisabolene production in S. cerevisiae was increased by 
20 times through deleting multiple distant genes related 
to intracellular mevalonate level and manipulating the 
expression level of three genes involved in mevalonate 
(MVA) pathway [10]. Swidah et  al. [11] reported that 
through the combinatorial effects of deletion of ADH1 to 
restore redox imbalance, expression of a butanol resist-
ant allele GCD1, and manipulation of acetyl-CoA for-
mation module, butanol production in S. cerevisiae was 
increased by more than 30 times. In a word, combina-
torial engineering host cell with heterologous pathway 
offers a promising alternative to achieve better metabolic 
flux balance and higher output of heterologous pathway.
Lycopene has long been used as functional food, nutra-
ceutical, pharmaceutical and cosmetic due to its anti-
oxidative and anti-cancer activities [12, 13]. Compared 
to chemical synthesis and extraction from tomatoes, 
microbial production of lycopene is more economical 
and sustainable. In recent years, lycopene production 
was successfully realized in Blakeslea trispora, E. coli 
and yeasts. However, regarding to food safety issues, it 
is controversial to use B. trispora or E. coli for lycopene 
synthesis, since E. coli would release endotoxin [14] and 
B. trispora requires the addition of cyclase inhibitors 
[15]. Saccharomyces cerevisiae is generally recognized as 
safe (GRAS), robust and preferred organism for indus-
trial use. To date, lycopene yield in S. cerevisiae was 
increased to 24.41 mg/g DCW with elaborate efforts in 
directed evolution and copy number variation of Crt 
genes from Xanthophyllomyces dendrorhous [16]. How-
ever, the lycopene yield was still much lower than that 
in E. coli [17, 18], which did not facilitate downstream 
extraction process. It was speculated that such low yield 
might be attributed to the incompatibility between S. 
cerevisiae and the heterologous pathway. Therefore, 
combinatorial engineering S. cerevisiae with a heterolo-
gous pathway may offer an effective solution to enhance 
lycopene yield.
In this study, heterologous carotenogenic pathway and 
its recruited host S. cerevisiae were combinatorially engi-
neered (Fig.  1c). Acetyl-CoA formation was enhanced 
by the deletion of YPL062W. A novel and optimal com-
bination of geranylgeranyl diphosphate synthase (CrtE, 
or GGPPS), phytoene synthase (CrtB) and phytoene 
desaturase (CrtI) was generated through related enzyme 
screening from diverse species. The expression level of 
CrtI, which has significant impact on lycopene produc-
tion as well as lycopene proportion in carotenoid, was 
fine-tuned by varying promoter strength and copy num-
ber. The influences of different cell mating types and 
potential distant genetic loci were also evaluated. Using 
this combinatorial engineering strategy, we achieved 
approximately 22-fold improvement (up to 54.63  mg/g 
DCW) in lycopene yield, which provides a good refer-
ence to increase the compatibility between heterologous 




All oligonucleotides were purchased from Invitrogen. 
Q5 DNA polymerase and PmeI restriction endonuclease 
were purchased from New England Biolabs (MA, USA). 
DNA purification and plasmids isolation kits were pur-
chased from Tiangen (Beijing, China). CloneJET PCR 
Cloning Kit was purchased from Fermentas (MD, USA). 
DNA sequencing was conducted by Genewiz (Beijing, 
China). Standards of lycopene and phytoene were pur-
chased from Sigma (Sigma-Aldrich, MO, USA). Stand-
ards of phytofluene, ζ-carotene and neurosporene were 
purchased from Express (Beijing, China).
Strains and culture conditions
Escherichia coli DH5α was used for routine cloning pro-
cedures, and was cultivated at 37  °C in Luria–Bertani 
(LB) medium containing 100 μg/mL ampicillin for selec-
tion. All the yeast strains engineered in this study are 
based on homologous haploid S. cerevisiae strains, CEN.
PK2-1C (MATa) or CEN.PK2-1D (MATα). Engineered 
yeast strains were selected on synthetic complete (SC) 
medium (0.67 % yeast nitrogen base without amino acids, 
2 % glucose, and appropriate amino acid drop-out mix), 
or YPD medium (2 % peptone, 1 % yeast extract, and 2 % 
glucose) with 200  μg/mL geneticin, 300  μg/mL hygro-
mycin B or 50  μg/mL bleomycin when needed. YPDG 
medium, consisting of 2  % glucose (unless otherwise 
indicated), 2 % peptone, 1 % yeast extract and 1 % D-(+)-
galactose, was used for shake-flask fermentations.
For shake-flask fermentation, yeast glycerol-stock was 
inoculated into a tube containing 2 mL YPD medium for 
overnight growth, then all the preculture was inoculated 
into a 250 mL shake-flask containing 25 mL YPD. After 
growing to the mid-log phase, the seed was transferred to 
50 mL fresh YPDG medium at an initial OD600 of 0.5 and 
grown at 30 °C for 48 h.
Construction of plasmids and strains
Saccharomyces cerevisiae strains and plasmids used in 
this study are summarized in Table 1. All oligonucleotides 
used for construction of the above plasmids and strains 
are listed in Additional file  1: Table S1. Construction 
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procedures of plasmids and integration modules are 
shown in Fig.  1b. All heterologous genes used for lyco-
pene biosynthesis were codon-optimized and synthesized 
by Genewiz (Beijing, China) for expression in S. cerevi-
siae. Endogenous truncated 3-hydroxy-3-methylglutaryl 
coenzyme A reductase (tHMG1) [19], promoters, termi-
nators and integration homologous arms (except TRP1 
homologous arm) used in this study were amplified from 
the genomic DNA of S. cerevisiae CEN.PK2-1C. Auxo-
troph markers (LEU2, HIS3) and TRP1 homologous 
arm were amplified from the genomic DNA of S. cer-
evisiae S288C. Antibiotic markers (KanMX, HphMX and 
BleMX) were amplified from plasmid pKan, pHph and 
pBle (owned by our laboratory), respectively. Overlap 
extension PCR (OE-PCR) was used to assemble the above 
parts into modules according to Additional file 1: Figure 
S1. The resulting modules were purified and cloned into 
pJET1.2/blunt vector following the protocol of CloneJET 
PCR Cloning Kit (Fermentas, MD, USA), obtaining plas-
mid pCY series (Table 1). Finally, all the integration mod-
ules were digested from plasmids with PmeI, then purified 
and transformed into yeast for genomic integration using 
the LiAc/SS carrier DNA/PEG method [20]. For gene 
deletions, one-step integration of PCR-amplified deletion 
cassettes was adopted [21]. Gene deletions and genomic 
integrations were verified by diagnostic PCR.
Fig. 1 Schematic representation of the engineering strategies for enhanced lycopene production in S. cerevisiae. a The engineered lycopene 
biosynthetic pathway in S. cerevisiae. Genetic modifications are noted by thick arrows. Red arrows indicate the heterologous lycopene biosynthetic 
pathway consisting of CrtE, CrtB and CrtI, which starts either from FPP (solid arrow) or directly from IPP and DMAPP (dashed arrow). The enzyme 
overexpressed in the described lycopene-producing strain is highlighted in blue. b Construction of plasmids and integration modules. c The ration-
ale of experiment design: combinatorial engineering of host cell and heterologous pathway
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Table 1 S. cerevisiae strains and plasmids used in this study
Description Source
Strain name
 CEN.PK2-1C MATa, ura3-52, trp1-289, leu2-3,112, his3Δ1, MAL2-8C, SUC2 EUROSCARF
 CEN.PK2-1D MATα, ura3-52, trp1-289, leu2-3,112, his3Δ1, MAL2-8C, SUC2 EUROSCARF
 SyBE_
Sc14C01
CEN.PK2-1C, Δgal80::HIS3 This study
 SyBE_
Sc14C02
CEN.PK2-1C, Δgal1 Δgal7 Δgal10::HIS3 This study
 SyBE_
Sc14C06
SyBE_Sc14C01, trp1::TRP1_TCYC1-BtCrtI-PGAL10-PGAL1-PaCrtB-TPGK1, leu2::LEU2_TACT1-tHMG1-PGAL10-PGAL1-PaCrtE-TGPM1 This study
 SyBE_
Sc14C07
SyBE_Sc14C02, trp1::TRP1_TCYC1-BtCrtI-PGAL10-PGAL1-PaCrtB-TPGK1, leu2::LEU2_TACT1-tHMG1-PGAL10-PGAL1-PaCrtE-TGPM1 This study
 SyBE_
Sc14C10
CEN.PK2-1C, Δgal1 Δgal7 Δgal10::HIS3, Δypl062w::KanMX This study
 SyBE_
Sc14C21
SyBE_Sc14C10, trp1::TRP1_TCYC1-AaCrtI-PGAL10-PGAL1-AaCrtB-TPGK1, leu2::LEU2_TACT1-tHMG1-PGAL10-PGAL1-PaCrtE-TGPM1 This study
 SyBE_
Sc14C51
SyBE_Sc14C10, trp1::TRP1_TCYC1-PaCrtI-PGAL10-PGAL1-AaCrtB-TPGK1, leu2::LEU2_TACT1-tHMG1-PGAL10-PGAL1-PaCrtE-TGPM1 This study
 SyBE_
Sc14C52
SyBE_Sc14C10, trp1::TRP1_TCYC1-BtCrtI-PGAL10-PGAL1-AaCrtB-TPGK1, leu2::LEU2_TACT1-tHMG1-PGAL10-PGAL1-PaCrtE-TGPM1 This study
 SyBE_
Sc14C53
SyBE_Sc14C10, trp1::TRP1_TCYC1-AaCrtI-PGAL10-PGAL1-PaCrtB-TPGK1, leu2::LEU2_TACT1-tHMG1-PGAL10-PGAL1-PaCrtE-TGPM1 This study
 SyBE_
Sc14C22
SyBE_Sc14C10, trp1::TRP1_TCYC1-PaCrtI-PGAL10-PGAL1-PaCrtB-TPGK1, leu2::LEU2_TACT1-tHMG1-PGAL10-PGAL1-PaCrtE-TGPM1 This study
 SyBE_
Sc14C23
SyBE_Sc14C10, trp1::TRP1_TCYC1-BtCrtI-PGAL10-PGAL1-PaCrtB-TPGK1, leu2::LEU2_TACT1-tHMG1-PGAL10-PGAL1-PaCrtE-TGPM1 This study
 SyBE_
Sc14C24
SyBE_Sc14C10, trp1::TRP1_TCYC1-AaCrtI-PGAL10-PGAL1-AaCrtB-TPGK1, leu2::LEU2_TACT1-tHMG1-PGAL10-PGAL1-SaCrtE-TGPM1 This study
 SyBE_
Sc14C54
SyBE_Sc14C10, trp1::TRP1_TCYC1-PaCrtI-PGAL10-PGAL1-AaCrtB-TPGK1, leu2::LEU2_TACT1-tHMG1-PGAL10-PGAL1-SaCrtE-TGPM1 This study
 SyBE_
Sc14C55
SyBE_Sc14C10, trp1::TRP1_TCYC1-BtCrtI-PGAL10-PGAL1-AaCrtB-TPGK1, leu2::LEU2_TACT1-tHMG1-PGAL10-PGAL1-SaCrtE-TGPM1 This study
 SyBE_
Sc14C56
SyBE_Sc14C10, trp1::TRP1_TCYC1-AaCrtI-PGAL10-PGAL1-PaCrtB-TPGK1, leu2::LEU2_TACT1-tHMG1-PGAL10-PGAL1-SaCrtE-TGPM1 This study
 SyBE_
Sc14C25
SyBE_Sc14C10, trp1::TRP1_TCYC1-PaCrtI-PGAL10-PGAL1-PaCrtB-TPGK1, leu2::LEU2_TACT1-tHMG1-PGAL10-PGAL1-SaCrtE-TGPM1 This study
 SyBE_
Sc14C26
SyBE_Sc14C10, trp1::TRP1_TCYC1-BtCrtI-PGAL10-PGAL1-PaCrtB-TPGK1, leu2::LEU2_TACT1-tHMG1-PGAL10-PGAL1-SaCrtE-TGPM1 This study
 SyBE_
Sc14C27
SyBE_Sc14C10, trp1::TRP1_TCYC1-AaCrtI-PGAL10-PGAL1-AaCrtB-TPGK1, leu2::LEU2_TACT1-tHMG1-PGAL10-PGAL1-AfCrtE-TGPM1 This study
 SyBE_
Sc14C57
SyBE_Sc14C10, trp1::TRP1_TCYC1-PaCrtI-PGAL10-PGAL1-AaCrtB-TPGK1, leu2::LEU2_TACT1-tHMG1-PGAL10-PGAL1-AfCrtE-TGPM1 This study
 SyBE_
Sc14C58
SyBE_Sc14C10, trp1::TRP1_TCYC1-BtCrtI-PGAL10-PGAL1-AaCrtB-TPGK1, leu2::LEU2_TACT1-tHMG1-PGAL10-PGAL1-AfCrtE-TGPM1 This study
 SyBE_
Sc14C59
SyBE_Sc14C10, trp1::TRP1_TCYC1-AaCrtI-PGAL10-PGAL1-PaCrtB-TPGK1, leu2::LEU2_TACT1-tHMG1-PGAL10-PGAL1-AfCrtE-TGPM1 This study
 SyBE_
Sc14C28
SyBE_Sc14C10, trp1::TRP1_TCYC1-PaCrtI-PGAL10-PGAL1-PaCrtB-TPGK1, leu2::LEU2_TACT1-tHMG1-PGAL10-PGAL1-AfCrtE-TGPM1 This study
 SyBE_
Sc14C29
SyBE_Sc14C10, trp1::TRP1_TCYC1-BtCrtI-PGAL10-PGAL1-PaCrtB-TPGK1, leu2::LEU2_TACT1-tHMG1-PGAL10-PGAL1-AfCrtE-TGPM1 This study
 SyBE_
Sc14C30
SyBE_Sc14C10, trp1::TRP1_TCYC1-AaCrtI-PGAL10-PGAL1-AaCrtB-TPGK1, leu2::LEU2_TACT1-tHMG1-PGAL10-PGAL1-BtCrtE-TGPM1 This study
 SyBE_
Sc14C60
SyBE_Sc14C10, trp1::TRP1_TCYC1-PaCrtI-PGAL10-PGAL1-AaCrtB-TPGK1, leu2::LEU2_TACT1-tHMG1-PGAL10-PGAL1-BtCrtE-TGPM1 This study
 SyBE_
Sc14C61
SyBE_Sc14C10, trp1::TRP1_TCYC1-BtCrtI-PGAL10-PGAL1-AaCrtB-TPGK1, leu2::LEU2_TACT1-tHMG1-PGAL10-PGAL1-BtCrtE-TGPM1 This study
 SyBE_
Sc14C62
SyBE_Sc14C10, trp1::TRP1_TCYC1-AaCrtI-PGAL10-PGAL1-PaCrtB-TPGK1, leu2::LEU2_TACT1-tHMG1-PGAL10-PGAL1-BtCrtE-TGPM1 This study





SyBE_Sc14C10, trp1::TRP1_TCYC1-PaCrtI-PGAL10-PGAL1-PaCrtB-TPGK1, leu2::LEU2_TACT1-tHMG1-PGAL10-PGAL1-BtCrtE-TGPM1 This study
 SyBE_
Sc14C32
SyBE_Sc14C10, trp1::TRP1_TCYC1-BtCrtI-PGAL10-PGAL1-PaCrtB-TPGK1, leu2::LEU2_TACT1-tHMG1-PGAL10-PGAL1-BtCrtE-TGPM1 This study
 SyBE_
Sc14C33
SyBE_Sc14C10, trp1::TRP1_TCYC1-AaCrtI-PGAL10-PGAL1-AaCrtB-TPGK1, leu2::LEU2_TACT1-tHMG1-PGAL10-PGAL1-TmCrtE-TGPM1 This study
 SyBE_
Sc14C63
SyBE_Sc14C10, trp1::TRP1_TCYC1-PaCrtI-PGAL10-PGAL1-AaCrtB-TPGK1, leu2::LEU2_TACT1-tHMG1-PGAL10-PGAL1-TmCrtE-TGPM1 This study
 SyBE_
Sc14C64
SyBE_Sc14C10, trp1::TRP1_TCYC1-BtCrtI-PGAL10-PGAL1-AaCrtB-TPGK1, leu2::LEU2_TACT1-tHMG1-PGAL10-PGAL1-TmCrtE-TGPM1 This study
 SyBE_
Sc14C65
SyBE_Sc14C10, trp1::TRP1_TCYC1-AaCrtI-PGAL10-PGAL1-PaCrtB-TPGK1, leu2::LEU2_TACT1-tHMG1-PGAL10-PGAL1-TmCrtE-TGPM1 This study
 SyBE_
Sc14C34
SyBE_Sc14C10, trp1::TRP1_TCYC1-PaCrtI-PGAL10-PGAL1-PaCrtB-TPGK1, leu2::LEU2_TACT1-tHMG1-PGAL10-PGAL1-TmCrtE-TGPM1 This study
 SyBE_
Sc14C35
SyBE_Sc14C10, trp1::TRP1_TCYC1-BtCrtI-PGAL10-PGAL1-PaCrtB-TPGK1, leu2::LEU2_TACT1-tHMG1-PGAL10-PGAL1-TmCrtE-TGPM1 This study
 SyBE_
Sc14C40
SyBE_Sc14C10, leu2::LEU2_TCYC1-RFP This study
 SyBE_
Sc14C41
SyBE_Sc14C10, leu2::LEU2_TCYC1-RFP-PGAL3 This study
 SyBE_
Sc14C42
SyBE_Sc14C10, leu2::LEU2_TCYC1-RFP-PGAL7 This study
 SyBE_
Sc14C43


















CEN.PK2-1D, Δgal1 Δgal7 Δgal10::HIS3, Δypl062w::KanMX, trp1::TRP1_TCYC1-BtCrtI-PGAL10-PGAL1-PaCrtB-TPGK1 This study
 SyBE_
Sc14D05
SyBE_Sc14D04, leu2::LEU2_TACT1-tHMG1-PGAL10-PGAL1-TmCrtE-TGPM1 This study
 SyBE_
Sc14D06
SyBE_Sc14D04, leu2::LEU2_TCYC1-BtCrtI-PGAL3-TACT1-tHMG1-PGAL10-PGAL1-TmCrtE-TGPM1 This study
 SyBE_
Sc14D07
SyBE_Sc14D04, leu2::LEU2_TCYC1-BtCrtI-PGAL7-TACT1-tHMG1-PGAL10-PGAL1-TmCrtE-TGPM1 This study
 SyBE_
Sc14D08
SyBE_Sc14D04, leu2::LEU2_TCYC1-BtCrtI-PGAL7-TACT1-tHMG1-PGAL10-PGAL1-TmCrtE-TGPM1, ΔYGLCtau3::HphMX_PGAL7-BtCrtI-TCYC1 This study
 SyBE_
Sc14D10
SyBE_Sc14D04, leu2::LEU2_TCYC1-BtCrtI-PGAL7-TACT1-tHMG1-PGAL10-PGAL1-TmCrtE-TGPM1, Δyjl064w::BleMX This study
 SyBE_
Sc14D11
SyBE_Sc14D04, leu2::LEU2_TCYC1-BtCrtI-PGAL7-TACT1-tHMG1-PGAL10-PGAL1-TmCrtE-TGPM1, Δrox1::BleMX This study
 SyBE_
Sc14D12
SyBE_Sc14D04, leu2::LEU2_TCYC1-BtCrtI-PGAL7-TACT1-tHMG1-PGAL10-PGAL1-TmCrtE-TGPM1, Δdos2::BleMX This study
 SyBE_
Sc14D13
SyBE_Sc14D04, leu2::LEU2_TCYC1-BtCrtI-PGAL7-TACT1-tHMG1-PGAL10-PGAL1-TmCrtE-TGPM1, Δrox1::BleMX, Δdos2::HphMX This study
 SyBE_
Sc14D14




 pJET1.2/blunt Blunt-end PCR fragments cloning vector Fermentas
 pCY01 pJET1.2/blunt possessing TRP1 homologous arm, TCYC1-AaCrtI-PGAL10-PGAL1-AaCrtB-TPGK1 This study
 pCY02 pJET1.2/blunt possessing TRP1 homologous arm, TCYC1-PaCrtI-PGAL10-PGAL1-PaCrtB-TPGK1 This study
 pCY03 pJET1.2/blunt possessing TRP1 homologous arm, TCYC1-BtCrtI-PGAL10-PGAL1-PaCrtB-TPGK1 This study
 pCY04 pJET1.2/blunt possessing LEU2 homologous arm with LEU2 marker, TACT1-tHMG1-PGAL10-PGAL1-PaCrtE-TGPM1 This study
Page 6 of 13Chen et al. Microb Cell Fact  (2016) 15:113 
Assay of extracellular glucose, ethanol, acetate 
and glycerol
The concentrations of residual glucose, ethanol, acetate 
and glycerol in the medium were determined by HPLC 
(Waters Corp., USA) with a refractive index detector. 
Aminex HPX-87H column (BioRad, CA) was used for 
separation at the column temperature of 65  °C. 5  mM 
H2SO4 was used as eluent with a flow rate of 0.6  mL/
min.
Assay of acetyl‑CoA
Cells were sampled during the course of lycopene shake-
flask fermentation for acetyl-CoA assay. Acetyl-CoA was 
extracted as previously described [22] and analyzed by 
the acetyl-CoenzymeA Assay Kit (Sigma-Aldrich). The 
acetyl-CoA concentration was normalized by dry cell 
weight.
Assay of promoter strength
Fluorescence intensity of red fluorescence protein (RFP) 
was used to characterize the strengths of GAL3, GAL7 
and GAL10 promoters as previously described [23]. The 
strain without promoter fused with RFP (SyBE_Sc14C40) 
was used as the negative control. Culturing procedures 
of all the test strains (SyBE_Sc14C40–SyBE_Sc14C43; 
Table  1) were the same as lycopene fermentation in 
shake-flasks. Every 6  h of cultivation, cells were har-
vested, washed and diluted with phosphate-buffered 
saline (PBS) into an OD600 of 0.3–0.4 for fluorescence 
assay. RFP fluorescence intensity was detected by Spec-
traMax M2 microplate reader with excitation and emis-
sion wavelengths at 587 and 611  nm, respectively. 
Promoter strength was determined as the ratio of the 
fluorescence to OD600 for each strain.
Extraction and analysis of carotenoid
Extraction of carotenoid was as described by Xie et  al. 
[24] with some modifications. Briefly, cells harvested 
from cultures were washed, resuspended in boiling 3  N 
HCl for 2 min, and cooled in an ice-bath for 3 min. Then, 
cells debris were washed twice with water, resuspended 
in acetone containing 1  % BHT (w/v), vortexed with 
glass beads (425–600 µm, Sigma) until colorless, and fol-
lowed by centrifugation. The acetone phase containing 
the extracted carotenoid was filtered for HPLC analysis. 
A HPLC system (Waters e2695) equipped with a BDS 
Hypersil C18 column (4.6 × 150 mm, 5 µm) and a UV/
VIS detector (Waters 2489) was used to analyze the pro-
duced carotenoid. The signals of phytoene, phytofluene, 
ζ-carotene, neurosporene and lycopene were detected 
at 287, 349, 401, 440 and 471 nm, respectively [25]. The 
mobile phase consisted of methanol–acetonitrile-dichlo-
romethane (21:21:8 v/v) with a flow rate of 1 mL/min at 
30 °C [26]. Total carotenoid was calculated as the sum of 
the above carotenoids.
Microscopy
Microscopic analysis was used to investigate lycopene 
formation of strain SyBE_Sc14C45 during shake-flask 
fermentation with YPDG medium. SyBE_Sc14C45 cul-
tivated in YPD medium (without galactose) was used as 
control. After 36  h of cultivation, cells were harvested, 
washed and diluted with sterile water into an OD600 of 
5.0. Images were taken with an Olympus CX41 (Olym-
pus, Tokyo, Japan).
Fed‑batch fermentation
Strain SyBE_Sc14D14 was selected for fed-batch fer-
mentation. Seed cultures were prepared by inoculating 
Table 1 continued
Description Source
 pCY05 pJET1.2/blunt possessing LEU2 homologous arm with LEU2 marker, TACT1-tHMG1-PGAL10-PGAL1-SaCrtE-TGPM1 This study
 pCY06 pJET1.2/blunt possessing LEU2 homologous arm with LEU2 marker, TACT1-tHMG1-PGAL10-PGAL1-AfCrtE-TGPM1 This study
 pCY07 pJET1.2/blunt possessing LEU2 homologous arm with LEU2 marker, TACT1-tHMG1-PGAL10-PGAL1-BtCrtE-TGPM1 This study
 pCY08 pJET1.2/blunt possessing LEU2 homologous arm with LEU2 marker, TACT1-tHMG1-PGAL10-PGAL1-TmCrtE-TGPM1 This study
 pCY09 pJET1.2/blunt possessing LEU2 homologous arm with LEU2 marker, TCYC1-RFP This study
 pCY10 pJET1.2/blunt possessing LEU2 homologous arm with LEU2 marker, TCYC1-RFP-PGAL3 This study
 pCY11 pJET1.2/blunt possessing LEU2 homologous arm with LEU2 marker, TCYC1-RFP-PGAL7 This study
 pCY12 pJET1.2/blunt possessing LEU2 homologous arm with LEU2 marker, TCYC1-RFP-PGAL10 This study
 pCY13 pJET1.2/blunt possessing LEU2 homologous arm with LEU2 marker, TCYC1-BtCrtI-PGAL3-TACT1-tHMG1-PGAL10-PGAL1-TmCrtE-
TGPM1
This study
 pCY14 pJET1.2/blunt possessing LEU2 homologous arm with LEU2 marker, TCYC1-BtCrtI-PGAL7-TACT1-tHMG1-PGAL10-PGAL1-TmCrtE-
TGPM1
This study
 pCY15 pJET1.2/blunt possessing YGLCtau3 homologous arm with HphMX marker, PGAL7-BtCrtI-TCYC1 This study
 pCY40 pJET1.2/blunt possessing YPRCdelta15 homologous arm with HphMX marker, PGAL1-INO2-TCPS1 This study
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250 µL of glycerol-stock into a 250 mL shake-flask con-
taining 25 mL YPD and culturing at 30 °C for 16 h to an 
OD600 of 6–7, and then 15 mL of precultures were inocu-
lated into a 2 L shake-flask containing 400 mL YPD and 
subcultured for an additional 8 h at 30 °C to an OD600 of 
5–6. Seed cultures were transferred into a 5  L bioreac-
tor (BaiLun, China) containing 2  L YPD batch medium 
at a 10 % (v/v) inoculum. Fermentation was carried out 
at 30  °C with an air flow rate of 1.5 vvm. The dissolved 
oxygen was kept at 30 % by adjusting the agitation speed 
from 400 to 700  rpm and pH was controlled at 6.0 by 
automatic addition of 6 M sodium hydroxide.
According to the employed galactose-inducible sys-
tem for lycopene biosynthesis, fed-batch fermentation 
was divided into two stages: cell growth stage and lyco-
pene production stage. During the first stage to achieve 
maximal cell growth, concentrated glucose solution 
(500 g/L) was fed periodically into bioreactors to keep 
the glucose concentration under 2  g/L. In the mean-
while, 100  mL of the concentrated yeast extract solu-
tion (400  g/L) was fed periodically into the bioreactor 
every 10 h. Once cell growth entered stationary phase, 
glucose and yeast extract feedings were ceased, and 
10  g/L of D-(+)-galactose was added to induce lyco-
pene biosynthesis. After the depletion of the residual 
glucose, cells began to consume ethanol converted by 
glucose consumption. Ethanol concentration was con-
trolled below 5 g/L by adjusting 100 % ethanol feeding 
rate until harvest.
Results and discussion
Construction of inducible lycopene biosynthesis pathway
To avoid the potential toxicity of lycopene, genes respon-
sible for carotenoid synthesis were placed under the con-
trol of galactose-regulated GAL promoters. Δgal1 Δgal7 
Δgal10 and Δgal80 were two routine strategies to employ 
GAL promoters, since Δgal1 Δgal7 Δgal10 eliminates 
galactose utilization and Δgal80 does not require galac-
tose for induction [27]. Here, S. cerevisiae SyBE_Sc14C01 
(Δgal80) and SyBE_Sc14C02 (Δgal1 Δgal7 Δgal10) were 
chosen as the host cells for lycopene production. The 
carotenogenic pathway was constructed by genomic inte-
gration of CrtE, CrtB, CrtI and tHMG1 in the respective 
hosts (Fig. 1a). As a result, strain SyBE_Sc14C07 (Δgal1 
Δgal7 Δgal10) with CrtE and CrtB from Pantoea agglom-
erans and CrtI from Blakeslea trispora produced 78.8 % 
higher lycopene yield (4.31  mg/g DCW) than strain 
SyBE_Sc14C06 (Δgal80) harboring the same Crt genes 
(2.43  mg/g DCW) after 48  h of shake-flask culture in 
YPDG medium (Additional file 1: Figure S2). Thus, strain 
SyBE_Sc14C02 (Δgal1 Δgal7 Δgal10) was selected as the 
host cell for the further study.
Enhancement of acetyl‑CoA pool by the deletion 
of YPL062 W
Δypl062w (Additional file  1: Table S2) was previously 
reported to enhance carotenoid production by increasing 
the intracellular mevalonate level [10], but the mecha-
nism was not clear. In order to testify whether Δypl062w 
is benefit to lycopene production, YPL062W was deleted 
in SyBE_Sc14C07, generating strain SyBE_Sc14C23. As a 
result, Δypl062w increased lycopene yield by more than 
1.5-fold when cultured in YPDG medium with 2 % glu-
cose (Fig.  2a), which is consistent with previous work 
[10]. Compared to strain SyBE_Sc14C07 with 0.51  g/L 
extracellular acetate accumulation, no acetate accumu-
lation was observed in strain SyBE_Sc14C23 (Fig.  2c). 
Furthermore, SyBE_Sc14C07 and SyBE_Sc14C23 were 
cultivated in YPDG media with higher (4 %) glucose. As 
shown in Fig.  2b and d, 10.84  mg/g DCW of lycopene 
together with very little amount of acetate was detected 
in SyBE_Sc14C23, whereas only 70  µg/g DCW of lyco-
pene and up to 5.04 g/L of acetate were obtained in SyBE_
Sc14C07. It was also observed that cell growth of strain 
without Δypl062w was abolished when acetate accumu-
lated up to 1.0 g/L (Fig. 2d), which is in accordance with 
Thomas et  al. [28]. Moreover, when SyBE_Sc14C07 was 
cultured in YPDG medium with 2  % glucose, different 
concentrations (0, 0.5, 1.0, 1.5  g/L) of acetic acid were 
added to the media at the time of 7 h when glucose was 
exhausted (indicated as arrow in Additional file  1: Fig-
ure S3). Cell growth was also abolished when the added 
acetic acid concentration exceeded 1.0  g/L (Additional 
file 1: Figure S3A). Lycopene yield was dropped by 98.4 % 
(from 4.31 mg/g DCW to 67 µg/g DCW) when additional 
0.5  g/L acetic acid was added (Additional file  1: Figure 
S3B). No lycopene production was detected when 1.0 g/L 
acetic acid was added (Additional file 1: Figure S3B), sug-
gesting acetate accumulation would be harmful to lyco-
pene biosynthesis. Thus, Δypl062w acted as an important 
role in S. cerevisiae to reduce acetate accumulation.
As is known, acetate is the direct precursor for cyto-
solic acetyl-CoA. Therefore, we assumed that Δypl062w 
would enhance cytosolic acetyl-CoA pool from acetate. 
As expected, the cytosolic acetyl-CoA concentrations in 
SyBE_Sc14C23 were increased by approximately 100  % 
than those in SyBE_Sc14C07 at early times (Fig.  2e, f ). 
When lycopene was rapidly accumulated, SyBE_Sc14C23 
demonstrated the same cytosolic acetyl-CoA level but 
higher lycopene production as compared to SyBE_
Sc14C07 (Fig. 2a, b, e, f ). This result suggested the expan-
sion on lycopene production might be derived from the 
increase in acetyl-CoA supplement, since the intracellu-
lar mevalonate level of Δypl062w strain was significantly 
increased during terpenoid production [10]. Therefore, 
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Δypl062w enhanced “trapping” the carbon from acetate 
accumulation toward acetyl-CoA, which consequently 
improved MVA pathway flux and further lycopene pro-
duction. Our findings made us a better understanding of 
the effect of Δypl062w on MVA pathway.
Optimal combination of CrtE, CrtB and CrtI by screening 
enzymes from diverse sources
It is known that enzymes from different organisms often 
vary in catalytic activities [29, 30]. Besides, host cell 
compatibility may also affect the optimal performance 
of heterologous enzymes [16, 31]. Thus, screening 
enzymes from diverse sources offers an effective strat-
egy to increase the productivity of heterologous pathway 
in specific host [29, 32]. To date, most of the caroteno-
genic genes employed in heterologous biosynthesis were 
derived from Pantoea, Paracoccus or Xanthophyllomyces 
species [33, 34]. However, in S. cerevisiae, the currently 
reported Crt genes for high-level carotenoid produc-
tion were only from X. dendrorhous [16, 24, 35]. In this 
study, we aimed to rebuild a carotenogenic pathway with 
high productivity in S. cerevisiae by screening enzymes 
Fig. 2 The effect of Δypl062w on lycopene production. S. cerevisiae SyBE_Sc14C07 and SyBE_Sc14C23 were cultivated in YPDG media containing 
different concentrations of glucose (2 %, left side; 4 %, right side), respectively, in shake-flasks for analysis of lycopene production (a, b), acetate accu-
mulation (c, d) and cytosolic acetyl-CoA level (e, f). The error bars represent standard deviation calculated from triplicate experiments
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(CrtE, CrtB, and CrtI) from some other species except 
X. dendrorhous. Five CrtEs originated from P. agglo-
merans (PaCrtE), Sulfolobus acidocaldarius (SaCrtE), 
Archaeoglobus fulgidus (AfCrtE), B. trispora (BtCrtE) 
and Taxus x media (TmCrtE), two CrtBs from P. agglo-
merans (PaCrtB) and Paracoccus sp. (formerly Agrobac-
terium aurantiacum) (AaCrtB), and three CrtIs from P. 
agglomerans (PaCrtI), Paracoccus sp. (AaCrtI) and B. 
trispora (BtCrtI) were selected for carotenoid biosyn-
thesis. As illustrated in Fig.  3, thirty lycopene-produc-
ing strains were constructed and their production was 
investigated. Consequently, the lycopene yield in strain 
SyBE_Sc14C35 harboring the best enzyme combination 
(TmCrtE, PaCrtB and BtCrtI) was increased by 7.5-fold, 
up to 36.75 mg/g DCW, and the lycopene proportion in 
carotenoid was 64.11 % (Fig. 3). This strain was used as 
the candidate for the further optimization.
In general, CrtE, one of the rate-limiting enzymes 
in carotenoid pathway [36], was found to be crucial to 
the production yield of overall carotenoid. As shown 
in Fig.  3, strains harboring AfCrtE, BtCrtE or TmCrtE 
showed much higher yield of total carotenoid than that 
harboring PaCrtE or SaCrtE. TmCrtE was reported to 
possess a larger pocket and higher affinity for farnesyl 
diphosphate (FPP) binding than other GGPPSs [30], thus 
it was reasonable that strain with TmCrtE achieved high 
carotenoid yield. CrtE from B. trispora [37] was firstly 
well expressed in S. cerevisiae and achieved quite high 
yield of overall carotenoid, demonstrating that BtCrtE 
would be a promising GGPPS candidate for further 
study. AfCrtE can directly utilize dimethylallyl pyroph-
osphate (DMAPP)/isopentenyl pyrophosphate (IPP) to 
synthesize geranylgeranyl diphosphate (GGPP) and thus 
avoid competing FPP for sterols biosynthesis [38], which 
might explain the improved carotenoid production cata-
lyzed by AfCrtE. In addition to AfCrtE, SaCrtE was also a 
bifunctional FPP/GGPP synthase [39] and has been dem-
onstrated to increase diterpenoids production [40, 41]. 
But it was difficult to interpret the low carotenoid yield 
by SaCrtE according to our current data, which might 
be ascribed to the insufficient expression of SaCrtE or its 
incompatibility with CrtB and CrtI.
Phytoene, synthesized by CrtB from GGPP, is the first 
intermediate of the carotenoid pathway. Then lycopene was 
generated by CrtI through four successive dehydrogena-
tion steps from phytoene (Fig. 1a). As illustrated in Fig. 3, 
rather than lycopene, phytoene was one of the major com-
ponents of the total carotenoid in most of our engineered 
strains, indicating that CrtI-catalyzed conversion from phy-
toene to lycopene was another rate-limiting step, which is 
consistent with previous reports [16, 35]. To be noted, all 
the strains harboring BtCrtI showed much better perfor-
mance than strains harboring PaCrtI or AaCrtI, irrespec-
tive of lycopene yield or proportion in carotenoid (Fig. 3). 
BtCrtI, an enzyme from eukaryotic organsims, was firstly 
well expressed in S. cerevisiae and found to be more suit-
able for high-level conversion from phytoene to lycopene in 
S. cerevisise according to our results. The molecular mecha-
nism for its high efficiency in conversion from phytoene to 
lycopene is an interesting topic in the field in future.
Fine‑tuning of BtCrtI and selection of homologous haploid 
yeast hosts
Despite the improved lycopene yield in SyBE_Sc14C35, 
approximately 26  % of the total carotenoid was phy-
toene, which indicated that the phytoene conversion 
Fig. 3 Combinatorial optimization of CrtE, CrtB and CrtI from diverse species. Thirty lycopene-producing strains were constructed by screening 
enzymes from various sources and tested for lycopene production. Pa, Pantoea agglomerans; Sa, Sulfolobus acidocaldarius; Af, Archaeoglobus fulgidus; 
Bt, Blakeslea trispora; Tm, Taxus x media; Aa, Paracoccus sp. (formerly Agrobacterium aurantiacum). The error bars represent standard deviation calcu-
lated from triplicate experiments
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directed by BtCrtI was not efficient enough. In order to 
achieve higher lycopene proportion, the expression level 
of BtCrtI needs to be fine-tuned. Here, BtCrtI was fine-
tuned by adjusting different promoters and integration 
copy numbers. The strengths of GAL promoters used 
in this step were characterized in strain SyBE_Sc14C10 
(CEN.PK2-1C, Δgal1 Δgal7 Δgal10, Δypl062w), and 
PGAL3 was found to be the weakest one (Additional file 1: 
Figure S4). When one additional copy of BtCrtI under 
the control of PGAL3 or PGAL7 was integrated in strain 
SyBE_Sc14C35, the lycopene proportion in the resulting 
strain SyBE_Sc14C44 or SyBE_Sc14C45 was increased by 
17.9 % (from 64.11 to 75.58 %) or 35.2 % (up to 86.68 %), 
respectively (Fig. 4). Moreover, a slight decrease in lyco-
pene yield was observed after another additional copy of 
PGAL7-BtCrtI integrated in SyBE_Sc14C45 (Fig. 4), which 
is similar to recent report [16]. To be noted, although the 
lycopene yield was modestly increased, the total carot-
enoid yield was decreased obviously after fine-tuning 
steps for higher lycopene proportion (Fig.  4). As shown 
in Additional file 1: Figure S5, most of the lycopene was 
accumulated in cell membrane, which is consistent with 
early reports [42, 43]. Rapid lycopene accumulation in 
cell membrane would lead to membrane stress or cell 
toxicity, which might explain the significant decrement in 
the content of total carotenoid after fine-tuning. There-
fore, increasing lycopene tolerance in S. cerevisiae would 
be an effective direction to improve lycopene yield.
Haploid cell type was reported to have significant influ-
ence on heterologous terpenoid production [44]. Jackson 
et  al. [45] found that MATa strain was more suitable to 
produce epi-cedrol than MATα strain, since MATa strain 
might synthesize more FPP for prenylation of the mat-
ing pheromone [46]. However, cell mating types did not 
have significant effect on linalool production [47]. Here, 
lycopene production in CEN.PK2-1C (MATa) and CEN.
PK2-1D (MATα) with the same genetic modifications 
was evaluated, respectively. The strains (SyBE_Sc14D05–
SyBE_Sc14D08) derived from CEN.PK2-1D (MATα) 
achieved 12–15  % higher lycopene yield than strains 
(SyBE_Sc14C35, SyBE_Sc14C44–SyBE_Sc14C46) from 
CEN.PK2-1C (MATa) (Fig.  4), suggesting that MATα 
strain was preferred in the case of lycopene produc-
tion. Finally, the strain SyBE_Sc14D07 (MATα) achieved 
lycopene yield of 46.26 mg/g DCW with a proportion of 
82.36 % (Fig. 4).
Effects of distant genetic loci on lycopene production
As the engineered metabolic pathways were highly 
inter-connected with the rest of cellular metabolism and 
tightly regulated [48], distantly located genetic loci in 
host cell could also have potential interactions with tar-
get pathway. As Δrox1, Δdos2 and Δyjl064w (Additional 
file  1: Table S2) were proved to greatly benefit carote-
noid production [5, 10], these three distant genetic loci 
were knocked out individually in strain SyBE_Sc14D07. 
As shown in Fig.  5, both Δrox1 and Δdos2 conferred a 
modest increase (8.7 and 5.7 %, respectively) in lycopene 
production as expected, while Δyjl064w led to 18.2  % 
decreased lycopene yield as compared to SyBE_Sc14D07. 
Moreover, the combination of Δrox1 and Δdos2 did not 
show a synergistic effect on lycopene production (Fig. 5), 
which is inconsistent with the results obtained by Trikka 
Fig. 4 Carotenoid production by fine-tuning of BtCrtI and select-
ing homologous haploid strains. BtCrtI expression was fine-tuned 
by adjusting copy number and promoter strength, and haploid 
cells with different mating types (a, α) were compared as well for 
carotenoid production. The error bars represent standard deviation 
calculated from triplicate experiments
Fig. 5 The effects of distant genetic loci on lycopene production. 
Three gene-deletion targets (ROX1, DOS2, and YJL064W) and one 
overexpression target (INO2) were investigated in S. cerevisiae SyBE_
Sc14D07 for lycopene production. The error bars represent standard 
deviation calculated from triplicate experiments
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et  al. [5]. These inconsistencies might be attributed to 
that the impact of perturbations in one strain may not be 
directly applied to another strain with a modified genetic 
background [1]. Consequently, a relatively higher lyco-
pene yield of 50.28  mg/g DCW was obtained in SyBE_
Sc14D11 with Δrox1.
As shown in Additional file  1: Figure S5, lycopene 
tended to accumulate in cell membrane and thus cause 
cell toxicity. Here, INO2 (Additional file  1: Table S2), an 
endogenous transcription factor related to cellular stress 
response [49, 50], was overexpressed in SyBE_Sc14D11. As 
a result, a lycopene yield of 54.63 mg/g DCW, the highest 
yield reported, was obtained in the resulting strain SyBE_
Sc14D14 in shake-flask cultivation (Fig.  5). INO2 was 
reported to alleviate alkanes (C9–C11) toxicity by regulat-
ing genes associated with efflux pumps, stress response, 
lipid metabolism and ergosterol biosynthesis in S. cer-
evisiae [51]. High-level expression of INO2 was proved 
to up-regulate phospholipid and sterol biosynthesis [52]. 
Therefore, increasing lycopene tolerance through modify-
ing membrane components (i.e. lipid, and ergosterol) may 
be the main reason for the improvement of lycopene yield 
via INO2. Therefore, INO2 was identified as a novel tar-
get for lycopene production in S. cerevisiae. Strain SyBE_
Sc14D14 was chosen for fed-batch fermentation.
Lycopene overproduction in fed‑batch fermentation
To evaluate the production performance of the engi-
neered strain SyBE_Sc14D14, fed-batch fermentation 
was performed at a 2 L scale using YPD as the medium 
(Fig.  6). Based on carbon restriction strategy, trace 
amount of acetate was observed during the whole process 
(Additional file 1: Figure S6). Eventually, a total carotenoid 
titer of 1.81 g/L (60.94 mg/g DCW), consisting of 3.99 % 
of phytoene, 4.87 % of neurosporene and 91.14 % of lyco-
pene, was obtained after 120  h of cultivation (Fig.  6). 
Lycopene yield of 55.56 mg/g DCW achieved in our work 
was the highest yield in yeast strains to date. However, the 
lycopene titer (1.65 g/L) was just similar to previous work 
by Xie et al. [16]. This is due to the relative low cell den-
sity, since the highest OD600 only reached 106 throughout 
the fermentation. Additionally, excessive accumulations 
of ethanol and glycerol were also observed during cell 
growth phase (Fig. 6a; Additional file 1: Figure S6), which 
competed carbon flow from biomass synthesis and 
implied redox imbalance of our engineered strain [53]. In 
future, to limit glucose below 0.5 g/L in growth phase will 
greatly increase cell density as well as reduce by-product 
(ethanol or glycerol) accumulation. Moreover, intracel-
lular and extracellular metabolomics analysis will be an 
efficient way to find some biomarkers for batch media or 
feeding solution optimization. Off-gas analysis will also 
be promising for more precise process control. As recent 
studies in media optimization have demonstrated great 
potential in lycopene overproduction [16, 54], we believe 
that lycopene production by our engineered strain would 
be further improved by continuous efforts in both meta-
bolic engineering and fermentation optimization.
Conclusions
In this work, lycopene overproduction was realized by 
combinatorial engineering of S. cerevisiae and lycopene 
biosynthesis pathway. Extracellular acetate accumula-
tion was reduced and cytosolic acetyl-CoA pool was 
enhanced through the deletion of YPL062W. A novel 
and optimal combination of CrtE, CrtB and CrtI was 
obtained by screening enzymes from diverse sources. 
It was also found that CrtI from B. trispora had signifi-
cant influence on lycopene yield as well as proportion in 
carotenoid. The proportion of lycopene was significantly 
increased via fine-tuning of CrtI. Then the effects of cell 
mating types, several potential distant targets (YJL064 W, 
ROX1, and DOS2), and INO2, a stress-related transcrip-
tion factor, were also investigated. Lycopene yield was 
stepwise improved by approximately 22-fold as compared 
to the starting strain. The highest reported lycopene yield 
(55.56 mg/g DCW) and titer (1.65 g/L) were achieved in 
5-L bioreactors, providing a good example for microbial 
overproduction of pharmaceutical and chemical prod-
ucts through combinatorial engineering of host cell and 
heterologous pathway.
Fig. 6 Lycopene production in fed-batch fermentation. a Profile of 
glucose, ethanol, cell density and lycopene accumulation of strain 
SyBE_Sc14D14 during fed-batch fermentation. b Percentage ratios of 
the produced carotenoid composition at 120 h. The red liquid in the 
bottles was the lycopene fermentation broth. The error bars represent 
standard deviation calculated from duplicate experiments
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